A brief treatment for veterans with PTSD: an open-label case-series study

被引:0
|
作者
Kindt, Merel [1 ]
Soeter, Marieke [2 ]
机构
[1] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands
[2] Netherlands Org Appl Sci Res TNO, Work Hlth & Technol, Leiden, Netherlands
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
reconsolidation; imagery rescripting; trauma memory; treatment; veterans; PTSD; POSTTRAUMATIC-STRESS-DISORDER; RECONSOLIDATION INTERVENTION; EMOTIONAL MEMORY; IMAGERY; FEAR; METAANALYSIS; PROPRANOLOL; EXTINCTION; EXPOSURE; EFFICACY;
D O I
10.3389/fpsyt.2023.1260175
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
IntroductionDespite the positive outcomes observed in numerous individuals undergoing trauma-focused psychotherapy for PTSD, veterans with this condition experience notably diminished advantages from such therapeutic interventions in comparison to non-military populations.MethodsIn a preliminary study we investigated the efficacy of an innovative treatment approach in a small sample of veterans (n = 7). Recognizing that accessing and targeting trauma memory in veterans with PTSD may be more challenging compared to other patient populations, we employed unique and personalized retrieval cues that engaged multiple senses and were connected to the context of their trauma. This was followed by a session focused on memory reconsolidation, which incorporated both psychological techniques (i.e., imagery rescripting) and a pharmacological component (i.e., 40 mg of propranolol).ResultsThe findings from this small-scale case series cautiously indicate that this brief intervention, typically consisting of only one or two treatment sessions, shows promise in producing significant effects on symptoms of PTSD, distress and quality of life.This is particularly noteworthy given the complex symptomatology experienced by the veterans in this study.ConclusionTo summarize, there are grounds for optimism regarding this brief treatment of combat-related PTSD. It appears that the potential for positive outcomes is far greater than commonly believed, as demonstrated by the encouraging results of this pilot study.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
    Robert, Sophie
    Hamner, Mark B.
    Durkalski, Valerie L.
    Brown, Mary W.
    Ulmer, Helen G.
    PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (01) : 69 - 80
  • [2] An Open-Label Study of Mirtazapine as Treatment for Combat-Related PTSD
    Alderman, Christopher P.
    Condon, John T.
    Gilbert, Andrew L.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) : 1220 - 1226
  • [3] Tralokinumab in the treatment of resistant atopic dermatitis: An open-label, retrospective case series study
    Pezzolo, Elena
    Naldi, Luigi
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (05) : E644 - E645
  • [4] Case series: Topiramate open-label treatment of children and adolescents with autism
    Hardan, A
    Jou, RJ
    Handen, BL
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 125S - 125S
  • [5] An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: A case series
    Paul, Joan
    Foss, Clare E.
    Hirano, Stefanie A.
    Cunningham, Tina D.
    Pariser, David M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (02) : 255 - 261
  • [6] Quetiapine improves sleep disturbances in combat veterans with PTSD - Sleep data from a prospective, open-label study
    Robert, S
    Hamner, MB
    Kose, S
    Ulmer, HG
    Deitsch, SE
    Lorberbaum, JP
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (04) : 387 - 388
  • [7] Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series
    Mazza, Manuela
    JOURNAL OF CANNABIS RESEARCH, 2021, 3 (01)
  • [8] Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series
    Manuela Mazza
    Journal of Cannabis Research, 3
  • [9] Methylone for the Treatment for PTSD: Initial Results From an Open-Label Study (IMPACT-1)
    Jones, Amanda
    Warner-Schmidt, Jennifer
    Stogniew, Martin
    Mandell, Blake
    Kwak, Hannah
    Miller, Paul W.
    Ching, Terence H. W.
    Averill, Lynnette
    Kelmendi, Benjamin
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 77 - 78
  • [10] Transient hypogammaglobulinemia and severe atopic dermatitis: Open-label treatment with immunoglobulin in a case series
    Breslin, Moira E.
    Lin, Joanna H.
    Roberts, Robert
    Lim, Kellie J.
    Stiehm, E. Richard
    ALLERGY & RHINOLOGY, 2016, 7 (02) : E69 - E73